AZN logo

AstraZeneca (AZN) Operating Profit

Annual Operating Profit

$10.00 B
+$1.28 B+14.69%

December 1, 2024

Summary

Performance

1-Year Change

+14.69%

3-Year Change

+7296.4%

5-Year Change

+475.55%

15-Year Change

+387.48%

AZN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.19%
AZN annual operating income is higher than 99.19% of companies in Healthcare sector

High & Low

All-time High

$11.55 B
AZN annual operating income is currently -13.41% below its historical high of $11.55 billion

3-Year Low

-$139.00 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
AZN previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
AZN next annual earnings announcement has not yet been scheduled

OtherAZNprofitabilitymetrics:

Annual Operating Margin

18.50%
AZN annual operating profit margin is 18.50%

Annual Revenue

$54.07 B
AZN annual revenue is $54.07 billion

Annual Net Income

$7.04 B
AZN annual net profit is $7.04 billion

Annual EPS

$2.25
AZN annual earnings per share is $2.25

Quarterly Operating Profit

$2.11 B
-$640.00 M-23.31%

September 30, 2024

Summary

Performance

3-Month Change

-23.31%

1-Year Change

+7.78%

3-Year Change

+290.72%

5-Year Change

+290.72%

AZN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.98%
AZN quarterly operating income is higher than 98.98% of companies in Healthcare sector

High & Low

All-time High

$4.52 B
AZN quarterly operating income is currently -53.42% below its historical high of $4.52 billion

3-Year Low

-$1.49 B

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

OtherAZNprofitabilitymetrics:

Quarterly Operating Margin

15.53%
AZN quarterly operating profit margin is 15.53%

Quarterly Revenue

$13.56 B
AZN quarterly revenue is $13.56 billion

Quarterly Net Income

$1.43 B
AZN quarterly net profit is $1.43 billion

Quarterly EPS

$0.46
AZN quarterly earnings per share is $0.46

TTM Operating Profit

$10.76 B
+$152.00 M+1.43%

September 30, 2024

Summary

Performance

3-Month Change

+1.43%

1-Year Change

+24.69%

3-Year Change

+716.86%

5-Year Change

+716.86%

AZN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.32%
AZN TTM operating income is higher than 99.32% of companies in Healthcare sector

High & Low

All-time High

$13.10 B
AZN TTM operating income is currently -17.86% below its historical high of $13.10 billion

3-Year Low

-$1.74 B

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

OtherAZNprofitabilitymetrics:

Annual Operating Margin

18.50%
AZN annual operating profit margin is 18.50%

TTM Revenue

$51.21 B
AZN TTM revenue is $51.21 billion

TTM Net Income

$6.50 B
AZN TTM net profit is $6.50 billion

TTM EPS

$2.08
AZN TTM earnings per share is $2.08

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

$10.00 B
AZN annual operating income is $10.00 billion

Annual Gross Profit

$43.87 B
AZN annual gross profit is $43.87 billion

Annual Operating Expenses

$33.86 B
AZN annual total operating expenses is $33.86 billion

AZN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+7.8%+24.7%
3 y3 years+7296.4%+290.7%+716.9%
5 y5 years+475.6%+290.7%+716.9%

AZN Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7296.4%-32.4%+241.6%at high+716.9%
5 y5-yearat high+7296.4%-32.4%+225.8%at high+716.9%
alltimeall time-13.4%+7296.4%-53.4%+143.6%-17.9%+716.9%

AstraZeneca Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
$10.00 B(+14.7%)
-
-
Sep 2024
-
$2.11 B(-23.3%)
$10.76 B(+1.4%)
Jun 2024
-
$2.75 B(-11.8%)
$10.61 B(+2.8%)
Mar 2024
-
$3.12 B(+11.6%)
$10.32 B(+8.5%)
Dec 2023
$8.72 B(+93.3%)
$2.79 B(+42.8%)
$9.51 B(+10.2%)
Sep 2023
-
$1.95 B(-20.4%)
$8.63 B(+9.0%)
Jun 2023
-
$2.46 B(+6.4%)
$7.92 B(+31.9%)
Mar 2023
-
$2.31 B(+20.8%)
$6.00 B(+31.3%)
Dec 2022
$4.51 B(-3346.0%)
$1.91 B(+53.4%)
$4.57 B(+289.1%)
Sep 2022
-
$1.25 B(+131.0%)
$1.18 B(-167.4%)
Jun 2022
-
$539.00 M(-38.6%)
-$1.74 B(+50.9%)
Mar 2022
-
$878.00 M(-159.0%)
-$1.16 B(+731.7%)
Dec 2021
-$139.00 M(-103.5%)
-$1.49 B(-11.2%)
-$139.00 M(-108.7%)
Sep 2021
-
-$1.67 B(-248.5%)
$1.59 B(-64.2%)
Jun 2021
-
$1.13 B(-40.5%)
$4.43 B(-3.4%)
Mar 2021
-
$1.90 B(+686.3%)
$4.59 B(+17.2%)
Dec 2020
$3.92 B(+125.3%)
$241.00 M(-79.4%)
$3.92 B(+27.7%)
Sep 2020
-
$1.17 B(-8.8%)
$3.07 B(+15.6%)
Jun 2020
-
$1.28 B(+5.2%)
$2.65 B(+42.5%)
Mar 2020
-
$1.22 B(-300.3%)
$1.86 B(+7.1%)
Dec 2019
$1.74 B(+236.8%)
-$609.00 M(-180.4%)
$1.74 B(+384.1%)
Sep 2019
-
$757.00 M(+53.5%)
$359.00 M(-30.3%)
Jun 2019
-
$493.00 M(-55.1%)
$515.00 M(-34.4%)
Mar 2019
-
$1.10 B(-155.2%)
$785.00 M(+104.4%)
Dec 2018
$516.00 M(-74.9%)
-$1.99 B(-317.7%)
$384.00 M(-73.2%)
Sep 2018
-
$913.00 M(+19.7%)
$1.43 B(-14.1%)
Jun 2018
-
$763.00 M(+9.6%)
$1.67 B(-8.8%)
Mar 2018
-
$696.00 M(-174.1%)
$1.83 B(-10.8%)
Dec 2017
$2.05 B(-42.6%)
-$939.00 M(-181.7%)
$2.05 B(-51.1%)
Sep 2017
-
$1.15 B(+24.2%)
$4.19 B(+3.0%)
Jun 2017
-
$925.00 M(+0.9%)
$4.07 B(+18.0%)
Mar 2017
-
$917.00 M(-23.8%)
$3.45 B(-3.4%)
Dec 2016
$3.57 B(+16.5%)
$1.20 B(+17.0%)
$3.57 B(+48.2%)
Sep 2016
-
$1.03 B(+239.3%)
$2.41 B(-5.6%)
Jun 2016
-
$303.00 M(-70.8%)
$2.55 B(-19.5%)
Mar 2016
-
$1.04 B(+2431.7%)
$3.17 B(+3.4%)
Dec 2015
$3.07 B(+28.3%)
$41.00 M(-96.5%)
$3.07 B(+4.7%)
Sep 2015
-
$1.17 B(+26.8%)
$2.93 B(+27.3%)
Jun 2015
-
$923.00 M(-1.1%)
$2.30 B(-7.5%)
Mar 2015
-
$933.00 M(-1071.9%)
$2.49 B(+4.1%)
Dec 2014
$2.39 B(-35.4%)
-$96.00 M(-117.7%)
$2.39 B(+27.0%)
Sep 2014
-
$541.00 M(-51.2%)
$1.88 B(-38.2%)
Jun 2014
-
$1.11 B(+32.7%)
$3.05 B(-2.9%)
Mar 2014
-
$836.00 M(-238.4%)
$3.14 B(-15.2%)
Dec 2013
$3.70 B(-53.1%)
-$604.00 M(-135.4%)
$3.70 B(-38.4%)
Sep 2013
-
$1.71 B(+42.2%)
$6.00 B(-7.0%)
Jun 2013
-
$1.20 B(-14.1%)
$6.45 B(-9.4%)
Mar 2013
-
$1.40 B(-17.9%)
$7.12 B(-9.7%)
Dec 2012
$7.88 B(-30.1%)
$1.70 B(-21.1%)
$7.88 B(+15.4%)
Sep 2012
-
$2.16 B(+15.4%)
$6.83 B(-23.6%)
Jun 2012
-
$1.87 B(-13.5%)
$8.94 B(-10.9%)
Mar 2012
-
$2.16 B(+231.8%)
$10.04 B(-11.0%)
Dec 2011
$11.28 B(-2.4%)
$651.00 M(-84.7%)
$11.28 B(-13.9%)
Sep 2011
-
$4.26 B(+43.7%)
$13.10 B(+16.5%)
Jun 2011
-
$2.96 B(-12.8%)
$11.24 B(-0.6%)
Mar 2011
-
$3.40 B(+37.7%)
$11.31 B(-2.1%)
Dec 2010
$11.55 B(+5.1%)
$2.47 B(+2.6%)
$11.55 B(+6.4%)
Sep 2010
-
$2.41 B(-20.7%)
$10.86 B(-6.8%)
Jun 2010
-
$3.03 B(-16.7%)
$11.65 B(+1.6%)
Mar 2010
-
$3.64 B(+105.6%)
$11.47 B(+4.4%)
Dec 2009
$10.99 B(+20.2%)
$1.77 B(-44.7%)
$10.99 B(+1.3%)
Sep 2009
-
$3.20 B(+12.4%)
$10.85 B(+6.6%)
Jun 2009
-
$2.85 B(-9.9%)
$10.18 B(+2.5%)
Mar 2009
-
$3.16 B(+93.5%)
$9.93 B(+8.6%)
Dec 2008
$9.14 B
$1.64 B(-35.4%)
$9.14 B(+3.5%)
DateAnnualQuarterlyTTM
Sep 2008
-
$2.53 B(-2.8%)
$8.83 B(+4.3%)
Jun 2008
-
$2.60 B(+9.7%)
$8.47 B(+3.1%)
Mar 2008
-
$2.37 B(+79.2%)
$8.22 B(+1.5%)
Dec 2007
$8.09 B(-1.5%)
$1.32 B(-38.9%)
$8.09 B(-7.7%)
Sep 2007
-
$2.17 B(-7.7%)
$8.77 B(+0.7%)
Jun 2007
-
$2.35 B(+4.3%)
$8.71 B(+2.6%)
Mar 2007
-
$2.25 B(+12.4%)
$8.49 B(+3.4%)
Dec 2006
$8.22 B(+26.4%)
$2.00 B(-4.9%)
$8.22 B(+4.7%)
Sep 2006
-
$2.11 B(-1.2%)
$7.85 B(+5.5%)
Jun 2006
-
$2.13 B(+7.8%)
$7.44 B(+5.9%)
Mar 2006
-
$1.98 B(+20.8%)
$7.03 B(+8.0%)
Dec 2005
$6.50 B(+43.0%)
$1.64 B(-3.5%)
$6.50 B(+5.9%)
Sep 2005
-
$1.70 B(-1.3%)
$6.14 B(+9.3%)
Jun 2005
-
$1.72 B(+18.2%)
$5.61 B(+13.5%)
Mar 2005
-
$1.45 B(+14.3%)
$4.95 B(+8.8%)
Dec 2004
$4.55 B(+13.5%)
$1.27 B(+8.4%)
$4.55 B(+13.1%)
Sep 2004
-
$1.17 B(+11.4%)
$4.02 B(+2.0%)
Jun 2004
-
$1.05 B(0.0%)
$3.94 B(+4.2%)
Mar 2004
-
$1.05 B(+41.2%)
$3.78 B(-5.5%)
Dec 2003
$4.01 B(+0.0%)
$745.00 M(-32.0%)
$4.01 B(+0.3%)
Sep 2003
-
$1.09 B(+22.6%)
$3.99 B(+4.8%)
Jun 2003
-
$892.93 M(-29.9%)
$3.81 B(-4.3%)
Mar 2003
-
$1.27 B(+74.2%)
$3.98 B(-0.6%)
Dec 2002
$4.01 B(-3.6%)
$731.21 M(-20.0%)
$4.01 B(-8.2%)
Sep 2002
-
$913.79 M(-14.1%)
$4.36 B(-2.3%)
Jun 2002
-
$1.06 B(-18.0%)
$4.47 B(+2.9%)
Mar 2002
-
$1.30 B(+19.0%)
$4.34 B(+6.6%)
Dec 2001
$4.16 B(-7.1%)
$1.09 B(+7.4%)
$4.07 B(-12.8%)
Sep 2001
-
$1.01 B(+8.0%)
$4.67 B(+2.1%)
Jun 2001
-
$940.00 M(-8.4%)
$4.57 B(-0.8%)
Mar 2001
-
$1.03 B(-39.2%)
$4.61 B(+3.0%)
Dec 2000
$4.47 B(+30.4%)
$1.69 B(+83.7%)
$4.47 B(+36.0%)
Sep 2000
-
$918.66 M(-5.8%)
$3.29 B(+0.3%)
Jun 2000
-
$975.39 M(+9.4%)
$3.28 B(-1.0%)
Mar 2000
-
$891.85 M(+77.0%)
$3.31 B(-52.3%)
Dec 1999
$3.43 B(+41.3%)
$504.00 M(-44.5%)
$6.94 B(+332.0%)
Sep 1999
-
$908.00 M(-10.0%)
$1.61 B(-47.0%)
Jun 1999
-
$1.01 B(-77.7%)
$3.03 B(+12.0%)
Mar 1999
-
$4.52 B(-193.6%)
$2.71 B(+350.0%)
Dec 1998
$2.43 B(+34.0%)
-$4.83 B(-307.3%)
$601.10 M(-36.5%)
Sep 1998
-
$2.33 B(+240.2%)
$946.31 M(+32.3%)
Jun 1998
-
$685.00 M(-71.7%)
$715.51 M(-69.1%)
Mar 1998
-
$2.42 B(-153.9%)
$2.31 B(+6.1%)
Dec 1997
$1.81 B(-3.0%)
-$4.49 B(-313.7%)
$2.18 B(-44.2%)
Sep 1997
-
$2.10 B(-8.1%)
$3.91 B(-5.2%)
Jun 1997
-
$2.28 B(0.0%)
$4.12 B(+0.1%)
Mar 1997
-
$2.28 B(-182.8%)
$4.12 B(+0.1%)
Dec 1996
$1.87 B(+11.1%)
-$2.76 B(-219.2%)
$4.11 B(+49.7%)
Sep 1996
-
$2.31 B(+1.5%)
$2.75 B(+16.0%)
Jun 1996
-
$2.28 B(0.0%)
$2.37 B(+405.5%)
Mar 1996
-
$2.28 B(-155.3%)
$468.49 M(+126.2%)
Dec 1995
$1.68 B(+40.9%)
-$4.12 B(-313.1%)
$207.09 M(-40.2%)
Sep 1995
-
$1.94 B(+411.0%)
$346.28 M(+111.0%)
Jun 1995
-
$378.70 M(-81.2%)
$164.08 M(-89.9%)
Mar 1995
-
$2.02 B(-150.6%)
$1.62 B(+12.5%)
Dec 1994
$1.19 B(+17.0%)
-$3.98 B(-327.3%)
$1.44 B(+2.1%)
Sep 1994
-
$1.75 B(-4.6%)
$1.41 B(+18.0%)
Jun 1994
-
$1.84 B(0.0%)
$1.20 B(+8.0%)
Mar 1994
-
$1.84 B(-145.8%)
$1.11 B(+8.7%)
Dec 1993
$1.02 B(+7.9%)
-$4.01 B(-361.2%)
$1.02 B(-79.8%)
Sep 1993
-
$1.54 B(-12.1%)
$5.03 B(+44.0%)
Jun 1993
-
$1.75 B(0.0%)
$3.50 B(+100.0%)
Mar 1993
-
$1.75 B
$1.75 B
Dec 1992
$944.90 M(-25.5%)
-
-
Dec 1991
$1.27 B(-2.9%)
-
-
Dec 1990
$1.31 B
-
-

FAQ

  • What is AstraZeneca annual operating income?
  • What is the all time high annual operating profit for AstraZeneca?
  • What is AstraZeneca annual operating profit year-on-year change?
  • What is AstraZeneca quarterly operating income?
  • What is the all time high quarterly operating profit for AstraZeneca?
  • What is AstraZeneca quarterly operating profit year-on-year change?
  • What is AstraZeneca TTM operating income?
  • What is the all time high TTM operating profit for AstraZeneca?
  • What is AstraZeneca TTM operating profit year-on-year change?

What is AstraZeneca annual operating income?

The current annual operating profit of AZN is $10.00 B

What is the all time high annual operating profit for AstraZeneca?

AstraZeneca all-time high annual operating income is $11.55 B

What is AstraZeneca annual operating profit year-on-year change?

Over the past year, AZN annual operating income has changed by +$1.28 B (+14.69%)

What is AstraZeneca quarterly operating income?

The current quarterly operating profit of AZN is $2.11 B

What is the all time high quarterly operating profit for AstraZeneca?

AstraZeneca all-time high quarterly operating income is $4.52 B

What is AstraZeneca quarterly operating profit year-on-year change?

Over the past year, AZN quarterly operating income has changed by +$152.00 M (+7.78%)

What is AstraZeneca TTM operating income?

The current TTM operating profit of AZN is $10.76 B

What is the all time high TTM operating profit for AstraZeneca?

AstraZeneca all-time high TTM operating income is $13.10 B

What is AstraZeneca TTM operating profit year-on-year change?

Over the past year, AZN TTM operating income has changed by +$2.13 B (+24.69%)